Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.
Alodia Farmacéutica SL, Santiago Grisolia 2, 28760 Tres Cantos, Madrid, Spain.
Int J Mol Sci. 2021 Feb 27;22(5):2370. doi: 10.3390/ijms22052370.
Transient receptor potential cation channel subfamily M member 8 (TRPM8) is a Ca non-selective ion channel implicated in a variety of pathological conditions, including cancer, inflammatory and neuropathic pain. In previous works we identified a family of chiral, highly hydrophobic β-lactam derivatives, and began to intuit a possible effect of the stereogenic centers on the antagonist activity. To investigate the influence of configuration on the TRPM8 antagonist properties, here we prepare and characterize four possible diastereoisomeric derivatives of 4-benzyl-1-[(3'-phenyl-2'-dibenzylamino)prop-1'-yl]-4-benzyloxycarbonyl-3-methyl-2-oxoazetidine. In microfluorography assays, all isomers were able to reduce the menthol-induced cell Ca entry to larger or lesser extent. Potency follows the order 342' > 342' 342' 342' with the most potent diastereoisomer showing a half inhibitory concentration (IC) in the low nanomolar range, confirmed by Patch-Clamp electrophysiology experiments. All four compounds display high receptor selectivity against other members of the TRP family. Furthermore, in primary cultures of rat dorsal root ganglion (DRG) neurons, the most potent diastereoisomers do not produce any alteration in neuronal excitability, indicating their high specificity for TRPM8 channels. Docking studies positioned these β-lactams at different subsites by the pore zone, suggesting a different mechanism than the known -(3-aminopropyl)-2-[(3-methylphenyl)methoxy]--(2-thienylmethyl)-benzamide (AMTB) antagonist.
瞬时受体电位阳离子通道亚家族 M 成员 8(TRPM8)是一种非选择性钙离子通道,涉及多种病理状况,包括癌症、炎症和神经性疼痛。在之前的工作中,我们鉴定了一组手性、高度疏水的β-内酰胺衍生物,并开始直观地感觉到手性中心可能对拮抗剂活性有影响。为了研究构型对 TRPM8 拮抗剂特性的影响,我们在这里制备并表征了 4-苄基-1-[(3'-苯基-2'-二苄基氨基)丙-1'-基]-4-苄氧羰基-3-甲基-2-氧代氮杂环丁烷的四个可能的非对映异构体。在微荧光测定中,所有异构体均能在不同程度上减少薄荷醇诱导的细胞 Ca 内流。根据半数抑制浓度(IC)在低纳摩尔范围内,所有异构体的效力遵循 342' > 342' 342' 342'的顺序,这一结果通过 Patch-Clamp 电生理学实验得到了证实。这四种化合物对其他 TRP 家族成员均显示出高受体选择性。此外,在大鼠背根神经节(DRG)神经元的原代培养物中,最有效的非对映异构体不会引起神经元兴奋性的任何改变,表明它们对 TRPM8 通道具有高度特异性。对接研究将这些β-内酰胺定位在不同的亚位点通过孔区,表明与已知的 -(3-氨基丙基)-2-[(3-甲基苯基)甲氧基]--(2-噻吩基甲基)苯甲酰胺(AMTB)拮抗剂不同的机制。